PLATINUM INVESTMENT MANAGEMENT LTD - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$3,668,944
-22.3%
204,398
-12.1%
0.14%
-12.8%
Q2 2023$4,724,350
+11.3%
232,6120.0%0.16%
+11.6%
Q1 2023$4,242,843
+32.5%
232,612
+50.2%
0.15%
+20.5%
Q4 2022$3,202,319
+98.2%
154,851
+150.6%
0.12%
+82.1%
Q3 2022$1,616,000
+3.2%
61,7800.0%0.07%
+13.6%
Q2 2022$1,566,000
-19.7%
61,7800.0%0.06%
-1.7%
Q1 2022$1,950,000
-22.0%
61,7800.0%0.06%
-14.3%
Q4 2021$2,500,000
+16.1%
61,7800.0%0.07%
+14.8%
Q3 2021$2,154,000
+4.2%
61,780
-17.9%
0.06%
+27.1%
Q2 2021$2,067,000
-2.2%
75,2900.0%0.05%
+2.1%
Q1 2021$2,114,000
-6.5%
75,290
-13.5%
0.05%
-9.6%
Q4 2020$2,260,000
+51.5%
87,0580.0%0.05%
+40.5%
Q3 2020$1,492,000
-30.7%
87,0580.0%0.04%
-24.5%
Q2 2020$2,154,000
+49.6%
87,058
-16.1%
0.05%
+36.1%
Q1 2020$1,440,000
+37.4%
103,7400.0%0.04%
+71.4%
Q4 2019$1,048,000
-15.9%
103,740
-24.2%
0.02%
-25.0%
Q3 2019$1,246,000
+7.2%
136,893
-6.4%
0.03%
+3.7%
Q2 2019$1,162,000
-36.4%
146,1930.0%0.03%
-37.2%
Q1 2019$1,826,000
+16.0%
146,1930.0%0.04%
-18.9%
Q4 2018$1,574,000
+17.8%
146,193
+52.5%
0.05%
+39.5%
Q3 2018$1,336,000
+106.5%
95,841
+81.4%
0.04%
+153.3%
Q2 2018$647,000
+320.1%
52,841
+428.4%
0.02%
+275.0%
Q1 2018$154,00010,0000.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders